Arrivent Biopharma, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
OrbiMed Advisors and affiliated entities reported a decrease in their beneficial ownership of ArriVent BioPharma, Inc. common stock to 7.5% due to an increase in the issuer's outstanding shares.